238 related articles for article (PubMed ID: 38182059)
21. Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies.
Du L; Chen L; Liu F; Wang W; Huang H
Int Rev Neurobiol; 2023; 171():255-297. PubMed ID: 37783558
[TBL] [Abstract][Full Text] [Related]
22. Intranasal delivery: circumventing the iron curtain to treat neurological disorders.
Jiang Y; Li Y; Liu X
Expert Opin Drug Deliv; 2015; 12(11):1717-25. PubMed ID: 26206202
[TBL] [Abstract][Full Text] [Related]
23. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
[TBL] [Abstract][Full Text] [Related]
24. The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview.
Djupesland PG; Messina JC; Mahmoud RA
Ther Deliv; 2014 Jun; 5(6):709-33. PubMed ID: 25090283
[TBL] [Abstract][Full Text] [Related]
25. Nose-to-brain delivery of antipsychotics using nanotechnology: a review.
Tan MSA; Parekh HS; Pandey P; Siskind DJ; Falconer JR
Expert Opin Drug Deliv; 2020 Jun; 17(6):839-853. PubMed ID: 32343186
[TBL] [Abstract][Full Text] [Related]
26. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
Md S; Mustafa G; Baboota S; Ali J
Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
[TBL] [Abstract][Full Text] [Related]
27. Nanotechnology-based delivery of therapeutics through the intranasal pathway and the blood-brain barrier for Alzheimer's disease treatment.
Boyetey MB; Choi Y; Lee HY; Choi J
Biomater Sci; 2024 Apr; 12(8):2007-2018. PubMed ID: 38456516
[No Abstract] [Full Text] [Related]
28. Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier.
Lee D; Minko T
Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959331
[TBL] [Abstract][Full Text] [Related]
29. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
Islam SU; Shehzad A; Ahmed MB; Lee YS
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318
[TBL] [Abstract][Full Text] [Related]
30. Recent expansions of novel strategies towards the drug targeting into the brain.
Alexander A; Agrawal M; Uddin A; Siddique S; Shehata AM; Shaker MA; Ata Ur Rahman S; Abdul MIM; Shaker MA
Int J Nanomedicine; 2019; 14():5895-5909. PubMed ID: 31440051
[TBL] [Abstract][Full Text] [Related]
31. Lipid Nanoparticles for Nasal/Intranasal Drug Delivery.
Cunha S; Amaral MH; Lobo JMS; Silva AC
Crit Rev Ther Drug Carrier Syst; 2017; 34(3):257-282. PubMed ID: 28845761
[TBL] [Abstract][Full Text] [Related]
32. Improving brain drug targeting through exploitation of the nose-to-brain route: a physiological and pharmacokinetic perspective.
Badhan RK; Kaur M; Lungare S; Obuobi S
Curr Drug Deliv; 2014; 11(4):458-71. PubMed ID: 24655046
[TBL] [Abstract][Full Text] [Related]
33. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
Vlieghe P; Khrestchatisky M
Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
[TBL] [Abstract][Full Text] [Related]
34. Current Nanoparticle Approaches in Nose to Brain Drug Delivery and Anticancer Therapy - A Review.
Ansari MA; Chung IM; Rajakumar G; Alzohairy MA; Alomary MN; Thiruvengadam M; Pottoo FH; Ahmad N
Curr Pharm Des; 2020; 26(11):1128-1137. PubMed ID: 31951165
[TBL] [Abstract][Full Text] [Related]
35. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
Curtis C; Zhang M; Liao R; Wood T; Nance E
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
[TBL] [Abstract][Full Text] [Related]
36. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
[TBL] [Abstract][Full Text] [Related]
37. Intranasal delivery of stem cells to the brain.
Jiang Y; Zhu J; Xu G; Liu X
Expert Opin Drug Deliv; 2011 May; 8(5):623-32. PubMed ID: 21417782
[TBL] [Abstract][Full Text] [Related]
38. Nasal delivery of neurotherapeutics
Rajput A; Pingale P; Dhapte-Pawar V
Front Pharmacol; 2022; 13():979682. PubMed ID: 36176429
[TBL] [Abstract][Full Text] [Related]
39. From nose to brain: understanding transport capacity and transport rate of drugs.
Wu H; Hu K; Jiang X
Expert Opin Drug Deliv; 2008 Oct; 5(10):1159-68. PubMed ID: 18817519
[TBL] [Abstract][Full Text] [Related]
40. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
